A drug described as a landmark in treating multiple sclerosis is being reviewed for use in Europe. Trials suggest that Ocrelizumab can slow damage to the brain in two forms of MS, which offers a lot of hope for the future.

A RACE of giants may have sprung from a mutant gene that first emerged around 1,500 years ago and which causes uncontrolled body growth, scientists believe.

Breast cancer screening saves the lives of two women for every one who receives potentially unnecessary treatment, international research out today suggests.

YOU walk into a room and search for somewhere to sit. It’s crowded but luckily a single chair is still free, next to what appears to be a respectable grandmother.